APIs
| 序号 | Product Name | 中文(wén)名稱 | CAS NO. | Registration Status |
| 1 | Lacosamide | 拉考沙胺 | 175481-36-4 | GMP、CEP、WC、USDMF |
| 2 | Vortioxetine hydrobromi→<de | 氫溴酸伏硫西(xī)汀 | 960203-27-4 | GMP、WC、USDMF |
| 3 | Brivaracetam | 布立西(xī)坦 | 357336-20-0 | GMP、USDMF |
| 4 | Ibrutinib | 伊布替尼 | 936563-96-1 | GMP、USDMF |
| 5 | Brexpiprazole | 布瑞哌唑 | 913611-97-9 | GMP、USDMF |
| 6 | Isavuconazonium sulfate | 硫酸艾沙康唑 | 946075-13-4 | GMP、USDMF |
| 7 | Agomelatine | 阿戈美(měi)拉汀 | 138112-76-2 | GMP、USDMF |
| 8 | Apalutamide | 阿帕他(tā)胺 | 956104-40-8 | GMP、USDMF |
| 9 | Relugolix | 瑞盧戈利 | 737789-87-6 | GMP、USDMF |
| 10 | Ilaprazole | 艾普拉唑 | 172152-36-2 | GMP、USDMF |
| 11 | Imidafenacin | 咪達那(nà)新 | 170105-16-5 | GMP、USDMF |
| 12 | Abemaciclib | 阿貝西(xī)利 | 1231929-97-7 | DMF Process |
| 13 | Alectinib HCL | 鹽酸艾樂(yuè)替尼 | 1256589-74-8 | DMF Process |
| 14 | Beraprost sodium | 貝前列素鈉 | 88475-69-8 | DMF Process |
| 15 | Cenobamate | 賽諾氨酯 | 913088-80-9 | DMF Process |
| 16 | Xanomeline Tartrate | 酒石酸呫諾美(měi)林(lín) | 152854-19-8 | Lab Scale |
| 17 | Givinostat | 吉維諾司他(tā) | 497833-27-9 | Lab Scale |
| 18 | Suzetrigine | VX-548 | 2649467-58-1 | Lab Scale |
| 19 | Vismodegib | 維莫德吉 | 879085-55-9 | Lab Scale |
| 20 | Dabrafenib | 達帕菲尼 | 1195765-45-7 | Lab Scale |
| 21 | Brigatinib | 布格替尼 | 1197953-54-0 | Lab Scale |
| 22 | Risdiplam | 利司撲蘭 | 1825352-65-5 | Lab Scale |
| 23 | Afatinib Dimaleate | 雙馬來(lái)酸阿法替尼 | 850140-73-7 | Lab Scale |
| 24 | Crizotinib | 克唑替尼 | 877399-52-5 | Lab Scale |
| 25 | Lenvatinib Mesylate | 甲磺酸樂(yuè)伐替尼 | 857890-39-2 | Lab Scale |
| 26 | Sotorasib | 索托拉西(xī)布 | 2296729-00-3 | Lab Scale |
| 27 | Lenalidomide | 來(lái)那(nà)度胺 | 191732-72-6 | In-house |
| 28 | Prasugrel HCl | 鹽酸普拉格雷 | 389574-19-0 | In-house |
| 29 | Ambrisentan | 安立生(shēng)坦 | 177036-94-1 | In-house |
| 30 | Tigecycline | 替加環素 | 220620-09-7 | In-house |
| 31 | Minodronic Acid | 米諾磷酸 | 155648-60-5 | In-house |
Disclaimer:
- This list of products and reference♠☆♠♥ to any product herein shoul✔> d not be construed and/o✘± r constituted transactεion where it is not permitt©±≤ed under patent law of t↑¥he country and/or is not authorized βby other laws and regulφ★ε§ations of the country.
- All the products under the p∞" atent are only for R&D ∑<use.



